CVS Health Corporation $CVS Holdings Lifted by Mizuho Markets Cayman LP

Mizuho Markets Cayman LP grew its holdings in shares of CVS Health Corporation (NYSE:CVS) by 133.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 321,755 shares of the pharmacy operator’s stock after buying an additional 184,005 shares during the period. CVS Health accounts for about 0.8% of Mizuho Markets Cayman LP’s investment portfolio, making the stock its 13th biggest holding. Mizuho Markets Cayman LP’s holdings in CVS Health were worth $24,257,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Harbor Capital Advisors Inc. raised its stake in CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 142 shares in the last quarter. Corundum Trust Company INC bought a new position in shares of CVS Health in the third quarter worth $29,000. Front Row Advisors LLC increased its holdings in shares of CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 371 shares during the period. Twin Peaks Wealth Advisors LLC acquired a new position in shares of CVS Health during the second quarter valued at $36,000. Finally, SOA Wealth Advisors LLC. raised its stake in shares of CVS Health by 36.9% during the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 131 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on CVS shares. Bank of America decreased their target price on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a research report on Tuesday, January 27th. Argus reduced their price target on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research note on Wednesday, January 28th. TD Cowen reiterated a “buy” rating on shares of CVS Health in a report on Friday. Robert W. Baird boosted their target price on CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, December 10th. Finally, Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a research report on Thursday, December 4th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $95.05.

CVS Health Stock Performance

NYSE:CVS opened at $75.81 on Tuesday. The company has a 50-day moving average of $78.08 and a 200-day moving average of $77.85. The firm has a market cap of $96.45 billion, a price-to-earnings ratio of 54.94, a price-to-earnings-growth ratio of 0.79 and a beta of 0.49. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. CVS Health Corporation has a twelve month low of $58.35 and a twelve month high of $85.15.

CVS Health (NYSE:CVS) last released its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.00 by $0.09. The business had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business’s quarterly revenue was up 8.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio is 192.75%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.